Detection and identification of platelet antibodies and antigens in the clinical laboratory

Immunohematology

Volumn 25, Issue 3, 2009, Pages 125-135

  Curtis, Brian R ^a   McFarland, Janice G ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; HEPARIN; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN;

ANTIBODY DETECTION; ANTIGEN DETECTION; CLINICAL LABORATORY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FLOW CYTOMETRY; IMMOBILIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE; THROMBOCYTE AGGREGATION;

ANTIGENS, HUMAN PLATELET; BLOOD PLATELET DISORDERS; HISTOCOMPATIBILITY TESTING; HUMANS; ISOANTIBODIES; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION;

EID: 77649155777     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Pfueller SL, Cosgrove L, Firkin BG, Tew D. Relationship of raised platelet IgG in thrombocytopenia to total platelet protein content. Br J Haematol 1981;49:293-302.
2. Schwartz KA. Platelet antibody: review of detection methods. Am J Hematol 1988;29:106-14.
3. LoBuglio AF, Court WS, Vinocur L, et al. Immune thrombocytopenic purpura. Use of a 1251-labeled antihuman IgG monoclonal antibody to quantify platelet-bound IgG. N Engl J Med 1983;309:459-63.
4. Shaw GM, Axelson J, Maglott JG, LoBuglio AF. Quantification of platelet-bound IgG by 1251-Staphylococcal protein A in immune thrombocytopenic purpura and other thrombocytopenic disorders. Blood 1984;63:154-61.
5. Schiffer CA, Young V. Detection of platelet antibodies using a micro-enzyme-linked immunosorbent assay (ELISA). Blood 1983;61:311-17.
6. Horai S, Claas FH, van Rood JJ. Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA). Comparative studies with the indirect immunofluorescence assay. Immunol Lett 1981;3:155-8.
7. Horai S, Claas FH, van Rood JJ. Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA) on artificial monolayers of platelets. Immunol Lett 1981;3:67-72.
8. von dem Borne AE, Verheugt FW, Oosterhof F, et al. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 1978;39:195-207.
9. Rosenfeld CS, Nichols G, Bodensteiner DC. Flow cytometric measurement of antiplatelet antibodies. Am J Clin Pathol 1987;87:518-22.
10. Lazarchick J, Hall SA. Platelet-associated IgG assay using flow cytometric analysis. J Immunol Methods 1986;87:257-65.
11. Ramos RR, Curtis BR, Chaplin H. A latex particle assay for platelet-associated IgG. Transfusion 1992;32:235-8.
12. Ogden DM, Asfour A, Koller C, Lichtiger B. Platelet cross-matches of single-donor platelet concentrates using a latex agglutination assay. Transfusion 1993;33:644-50.
13. Shibata Y, Juji T, Nishizawa Y, et al. Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang 1981;41:25-31.
14. Rachel JM, Summers TC, Sinor LT, Plapp FV. Use of a solid phase red blood cell adherence method for pre-transfusion platelet compatibility testing. Am J Clin Pathol 1988;90:63-8.
15. Furihata K, Nugent DJ, Bissonette A, et al. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glyco-protein IIIa. J Clin Invest 1987;80:1624-30.
16. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-6.
17. Menitove JE, Pereira J, Hoffman R, et al. Cyclic thrombocytopenia of apparent autoimmune etiology. Blood 1989;73:1561-9.
18. McMillan R, Tani P, Millard F, et al. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987;70:1040-5.
19. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PlA1 and PIA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989;83:1778-81.
20. McFarland JG, Aster RH, Bussel JB, et al. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. Blood 1991;78:2276-82.
21. Metcalfe P, Watkins NA, Ouwehand WH, et al. Nomenclature of human platelet antigens. Vox Sang 2003;85:240-5.
22. Curtis BR, Edwards JT, Hessner MJ, et al. Blood group A and B antigens are strongly expressed on platelets of some individuals. Blood 2000;96:1574-81.
23. Curtis BR, McFarland JG. Platelet immunology and alloimmunization. In: Simon TL, Dzik WH, Snyder E, et al., eds. Rossi's principles of transfusion medicine. Philadelphia: Lippincott Williams & Wilkins, 2008:203-17.
24. Smith GA, Ranasinghe E, Ouwehand WH. The importance of using multiple techniques for detection of platelet antibodies. Vox Sang 2007;93:306-8.
25. Garratty G, Arndt P. Applications of flow cytofluorometry to transfusion science. Transfusion 1995;35:157-78.
26. Visentin GP, Wolfmeyer K, Newman PJ, Aster RH. Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion 1990;30:694-700.
27. Curtis BR, McFarland JG, Wu GG, et al. Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood 1994;84:176-83.
28. Von Drygalski A, Curtis BR, Bougie DW, et al. Vancomycin-induced immune thrombocytopenia. N Engl J Med 2007;356:904-10.
29. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580-7.
30. Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 2009;7:911-18.
31. Christopoulos CG, Kelsey HC, Machin SJ. A flow-cytometric approach to quantitative estimation of platelet surface immunoglobulin G. Vox Sang 1993;64:106-15.
32. Stockelberg D, Hou M, Jacobsson S, et al. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA. Eur J Haematol 1996;56:72-7.
33. Hezard N, Simon G, Mace C, et al. Is flow cytometry accurate enough to screen platelet autoantibodies? Transfusion 2008;48:513-18.
34. Davoren A, Bussel J, Curtis BR, et al. Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP). Am J Hematol 2005;78:193-7.
35. Kohler M, Dittmann J, Legier TJ, et al. Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching. Transfusion 1996;36:250-5.
36. Skogen B, Christiansen D, Husebekk A. Flow cytometric analysis in platelet crossmatching using a platelet suspension immunofluorescence test. Transfusion 1995;35:832-6.
37. Rachel JM, Sinor LT, Tawfik OW, et al. A solid-phase red cell adherence test for platelet cross-matching. Med Lab Sci 1985;42:194-5.
38. Lin M, Shieh SH, Liang DC, et al. Neonatal alloimmune thrombocytopenia in Taiwan due to an antibody against a labile component of HPA-3a (Baka). Vox Sang 1995;69:336-40.
39. Harrison CR, Curtis BR, McFarland JG, et al. Severe neo-natal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays. Transfusion 2003;43:1398-402.
40. Hewitt J, Burton IE. Incidence of autoantibodies to GPIIb/IIIa in chronic autoimmune thrombocytopenic purpura may be overestimated by the MAIPA. Br J Haematol 1994;86:418-20.
41. Klee GG. Human anti-mouse antibodies. Arch Pathol Lab Med 2000;124:921-3.
42. Helmberg W, Folsch B, Wagner T, Lanzer G. Detection and differentiation of platelet-specific antibodies by flow cytometry: the bead-mediated platelet assay. Transfusion 1997;37:502-6.
43. Bakchoul T, Meyer O, Agaylan A, et al. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads. Transfusion 2007;47:1363-8.
44. Fujiwara K, Shimano K, Tanaka H, et al. Application of bead array technology to simultaneous detection of human leucocyte antigen and human platelet antigen antibodies. Vox Sang 2009;96:244-51.
45. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 1998;59:313-22.
46. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia. New York: Marcel Dekker, 2000:43-80.
47. Warkentin TE. Laboratory testing for heparin-induced thrombocytopenia. J Thromb Thrombolysis 2000;10(Suppl 1):35-45.
48. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992;68:95-6.
49. Warkentin TE. Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies-distinguishing "signal" from "noise". Thromb Haemost 2008;100:523-4.
50. Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 2008;100:678-84.
51. Dellaria SM, Greilich PE, Sarode R. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test. Anesth Analg 2008;107:379-81.
52. Warkentin TE, Sheppard JA, Moore JC, et al. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med 2005;146:341-6.
53. Amiral J, Wolf M, Fischer A, et al. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 1996;92:954-9.
54. McFarland JG, Curtis BR, Lochowicz AJ, et al. Correlation of PF4 ELISA results and clinical likelihood of HIT-can we improve on specificity? Blood 2008;(Suppl) 112:3423.
55. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986;67:27-30.
56. Hurd CM, Cavanagh G, Schuh A, et al. Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms. Vox Sang 2002;83:1-12.
57. Curtis BR. Genotyping for human platelet alloantigen polymorphisms: applications in the diagnosis of alloimmune platelet disorders. Semin Thromb Hemost 2008;34:539-48.
58. Skogen B, Bellissimo DB, Hessner MJ, et al. Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion 1994;34:955-60.
59. Nauck MS, Gierens H, Nauck MA, et al. Rapid genotyping of human platelet antigen 1 (HPA-1) with fluorophore-labelled hybridization probes on the LightCycler. Br J Haematol 1999;105:803-10.
60. Randen I, Sorensen K, Killie MK, Kjeldsen-Kragh J. Rapid and reliable genotyping of human platelet antigen (HPA)-1, -2, -3, -4, and -5 a/b and Gov a/b by melting curve analysis. Transfusion 2003;43:445-50.
61. Kjaer KM, Jaegtvik S, Husebekk A, Skogen B. Human platelet antigen 1 (HPA 1) genotyping with 5′ nuclease assay and sequence-specific primers reveals a single nucleotide deletion in intron 2 of the HPA 1a allele of platelet glycoprotein IIIa. Br J Haematol 2002;117:405-8.
62. Bugert P, McBride S, Smith G, et al. Microarray-based genotyping for blood groups: comparison of gene array and 5′-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005;45:654-9.
63. de Haasa M, van der Schoota CE, Beiboera SHW, et al. Red blood cell and platelet genotyping: from current practice to future high-throughput donor typing. Transfus Med Hemother 2006;33:260-6.
64. Curtis BR, Fick A, Lochowicz AJ, et al. Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B. Transfusion 2008;48:358-64.
65. Garritsen HS, Fan AX, Bosse N, et al. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for genotyping of human platelet-specific antigens. Transfusion 2009;49:252-8.
66. Bertrand G, Bianchi F, Chenet C, et al. New mutation in the platelet beta3-integrin gene: implication for the diagnosis of fetomaternal alloimmunization. Transfusion 2006;46:2138-41.
67. Skogen B, Wang R, McFarland JG, Newman PJ. A dinucleotide deletion in exon 4 of the PlA2 allelic form of glycoprotein IIIa: implications for the correlation of serologic versus genotypic analysis of human platelet alloantigens. Blood 1996;88:3831-6.
68. Smith GA, Rankin A, Riddle C, et al. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele. Vox Sang 2007;93:325-30.